Syntheses of three regioisomers of aromatic-substituted oxazolinyl-phosphinyl-[2.2]paracyclophanes, pseudo-geminal, pseudo-ortho and ortho, have been carried out or, in the latter two cases, newly developed. It has therefore been demonstrated that all aromatic-substituted isomers relevant for use as chelating ligands for asymmetric catalysis are accessible. These P,N-ligands, along with their diastereoisomers, were shown to exhibit widely differing activity and enantioselectivity (up to 89% ee) in the Pd-catalyzed asymmetric allylic alkylation reaction. 
Introduction
Planar chiral substituted [2.2] paracyclophanes have often been used as ligands in asymmetric catalysis. 1, 2 Perhaps the most famous example is PHANEPHOS, a planar chiral equivalent of BINAP, which, amongst other applications, [3] [4] [5] [6] [7] exhibited a higher activity and enantioselectivity than BINAP in the Rh-catalyzed hydrogenation of the tetrahydropyrazine precursor to the HIV protease inhibitor
Crixivan (86 vs. 56% ee). 8 There are three aromatic disubstitution patterns available to [2.2] paracyclophane which give compounds geometrically capable of chelating a metal and therefore applicable as chiral ligands for asymmetric catalysts. Despite this, all studies to date have concentrated on the development and use of ligands based on only one of these patterns. The closest exception involves the synthesis of iso-FHPC, the pseudogeminal analogue of 5-formyl-4-hydroxy [2.2] paracyclophane (FHPC). [9] [10] [11] [12] [13] FHPC is an established precursor to [2.2] paracyclophane Schiff bases, salens 14, 15 and hydroxy-amines 16, 17 which have been used in asymmetric additions of diorganozincs to aldehydes and imines, 18,19 sulfoxidations, 20 and the trimethylsilylcyanation of benzaldehyde. 21 However, to the best of our knowledge, the conversion of iso-FHPC into similar ligands and their use in asymmetric catalysis has not yet been published. We therefore decided to address this general absence by demonstrating that all three aromatic-disubstituted [2.2] paracyclophane isomers can be synthesized using established [2.2] paracyclophane chemistry and that they are all effective as ligands in asymmetric catalysis. The compounds chosen were the oxazolinyl-phosphinyl- [2.2] paracyclophanes, P,N-ligands 22, 23 designed by Pelter and Hou. 24, 25 Hou showed that use of the pseudo-geminal isomers gave up to 90% ee in the Pd-catalyzed allylic alkylation reaction. 26 This paper will describe the syntheses of the pseudo-geminal, pseudo-ortho and ortho analogues of these compounds ( Figure 1 ) and compare their effectiveness as ligands in the same allylic alkylation reaction. 
Results and Discussion
By taking advantage of literature-described directing effects, we were able to synthesize both diastereoisomers of each of the three desired aryl-substituted regioisomers of phosphinyloxazolinyl [2.2] paracyclophane 1-3. iso-Propyl was chosen as the substituent on the oxazoline ring on account of the inexpense of the amino alcohol required (valinol) and its effectiveness as a sterically demanding group which is not so bulky as to inhibit reactions.
Synthesis of Pseudo-Geminal Isomers
Following previously described syntheses of 1 and similar derivatives, 24, 25, 27, 28 racemic carboxylic acid 4 was converted to the acid chloride, reacted with L-valinol and cyclized under Bryce's conditions 29 to
give an inseparable mixture of diastereoisomers 5 (Scheme 1). The pseudo-geminal substitution pattern was attained by exploiting a directing effect, which occurs during iron-catalyzed bromination. 30 The resulting bromides 6a and 6b were separable by column chromatography. However, this reaction rarely proceeded to completion, even if commercial FeBr 2 or FeBr 3 was used as catalyst, and bromide 6a often had to be used in the next step as an inseparable mixture with 5. The bromides 6 were converted to the target compounds 1 by bromo-lithium exchange using t-BuLi followed by reaction with ClPPh 2 .
Interestingly, it was found that the diastereomeric phosphines 1a and 1b could be far more easily separated from the oxazolinyl [2.2] paracyclophane by-products (resulting from protonation of the lithium intermediates), by column chromatography, if a 3-component solvent system (pentane/DCM/EtOAc [20:4:1]) was used instead of the more usual 2-component system (pentane/EtOAc).
The absolute configurations of 1 were checked by preparation of 6a, in the same manner, from enantiopure carboxylic acid (-)-(R P ) 4. 
Synthesis of Pseudo-Ortho Isomers
The pseudo-ortho substitution pattern was set up early on in the synthesis by starting from dibromide 8, prepared according to the procedure by Reich and Cram 32a with the improvements of Pye and Rossen 8 and Braddock 32b (Scheme 2). Its synthesis involves dibromination of [2.2] paracyclophane to give a mixture of isomers from which the highly insoluble pseudo-para dibromide 7 can be crystallized.
Thermal isomerization of 7 leaves the pure pseudo-ortho dibromide 8 alone in solution after cooling. Dibromide 8 was converted to the mono-carboxylic acid 9 as previously described. 33 This was then converted to the diastereotopic bromo-oxazolinyl [2.2] paracyclophanes 10 (Scheme 3) in the same manner as for the pseudo-geminal compounds described above. Oxazolines 10a and 10b were inseparable at this stage, but the corresponding phosphines 2, synthesized by lithiation and reaction with ClPPh 2 , had different R f values on silica, so could be separated by chromatography. Using the standard technique, yields of only 9 and 11%, of 2a and 2b, respectively, were obtained and this was attributed to phosphine oxidation during work-up and lengthy chromatographic separation. This was despite degassing of the solvents prior to use by bubbling argon through them while under sonication.
However, during later research with 4-methoxyphenylphosphine derivatives, a novel work-up procedure was developed and the yields improved to 34 and 32%. This procedure is described later in the 'Asymmetric Catalysis' section. The absolute configurations of 2a and 2b were determined by the synthesis of 2b from enantiopure dibromide (+)-(S P ) 8. This was obtained by resolution of the racemate by preparative chiral HPLC (see Experimental Section).
SCHEME 3

Synthesis of Ortho Isomers
Ortho-substituted phosphinyl-oxazolinyl [2.2] paracyclophanes similar to 3 ( Figure 1 ) have been previously synthesized in our group by a metal-phosphine exchange of ortho oxazolinyl-palladacycles.
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Although efficient, the use of stoichiometric (1.1 eq) palladium acetate is expensive so an alternative procedure was sought. Attempted ortho-directed lithiations proved problematic due to competitive 1,2-addition of the alkyl lithium to the oxazoline, and 1,4-addition to the [2.2] paracyclophane backbone. 28 Hou, however, showed that ortho-lithiation of the diastereotopic mixture of oxazolinyl [2.2] paracyclophanes 5, using n-BuLi with TMEDA in Et 2 O, was successful, and that after quenching with PhSSPh or PhSeSePh, a mixture of the desired ortho products, as well as those resulting 9 formation of the oxazoline 16a, but this was unsuccessful and only the ring-opened product 13a
(actually the precursor of 16a) could be isolated in 10% yield.
SCHEME 4
14b: R = CONEt 2
15b: R = H
On treatment with Tf 2 O, the hydroxy-amides 15 underwent simultaneous cyclization and triflation 38 of the phenol group to give oxazolinyl-triflates 18 (Scheme 5). Subsequent nucleophilic aromatic substitution of the triflate with Ph 2 PK gave the desired ortho phosphinyl-oxazolines 3. Inspection of the NMR spectra of 3a and 3b is very interesting and reveals information about the compounds'
conformations. The chemical shift of the CH proton in the oxazoline ring (identified by COSY, DEPT 10 and HETCOR NMR experiments) is 3.33 ppm for 3a and 2.99 ppm for 3b. The increased shielding occuring in 3b is attributed to delocalization of electron density from the P-lone pair, through the π-system, onto the N-atom of the oxazoline ring. Correspondingly, 31 P NMR of 3b shows the P-atom to be more deshielded (1.48 ppm) than that of 3a (0.20 ppm). In conclusion, 3b must have the oxazoline, Plone pair and [2.2] paracyclophane aromatic ring in conjugation, whereas 3a does not. 
Asymmetric Catalysis
Asymmetric allylic alkylation was chosen as a test reaction for the new ligands to make a good comparison with Hou's work with compounds 1. 25 As hoped, a different positional isomer of the same ligand gave a much higher ee; pseudo-ortho 2a gave 82% ee where the original pseudo-geminal derivative gave 56% ee (Table 1) . Rather than simply being an effect of the bite angle at the metal in the active catalyst, this result must arise from the chiral environment being entirely different to that of the complex formed with 1a. As shown in Figure 2 , in 1a, half of the [2.2] paracyclophane backbone shields one side of the active site, whereas 2a could form a pseudo C2-symmetric type complex. This argument is especially relevant when one considers that the opposite diastereoisomers of the pseudo-ortho ligands gave opposite enantiomers of the product (entries 3 and 4), whereas the pseudo-geminal and ortho ligands gave the same enantiomer (entries 1, 2, 5 and 6). The latter selectivities must depend more strongly on the stereochemistry of the oxazoline substituent than that of the [2.2] Hou showed that the allylic alkylation could be optimized by using derivatives of the pseudo-geminal compounds with a di(4-methoxyphenyl)phosphinyl group in place of the diphenylphosphinyl group. We therefore synthesized such derivatives 19 of the pseudo-ortho compounds (Figure 3 ), using the same technique as for 2, but using (MeOC 6 H 4 ) 2 PCl instead of Ph 2 PCl. These electron rich phosphines were found to be more susceptible to oxidation and the oxides could not be reduced by the usual method using HSiCl 3 .
8 However, the yields could be improved from 9 and 6% (of 19a and 19b, respectively) to 32 and 31% by modifying the work-up. Hence, in place of the addition of degassed aq NH 4 Cl and extraction with degassed DCM, 2 equiv of Et 3 N were added (to quench HCl formed later) along with Et 2 O and the mixture suspended directly onto silica. After drying, this was placed atop a silica column and chromatography carried out as quickly as possible to give the separated diastereoisomers. noted that the Ph-substituted products 22 were pseudo enantiomers of the i-Pr-analogues 2 because Dphenylglycinol was used. Accordingly, the products from the allylic alkylation reaction were the opposite enantiomers.) It was also found that the diastereoisomers could be separated at the amide stage.
Cyclization to the oxazolines 21 required harsher conditions than the i-Pr analogues; an extra equiv of each reagent was added and the mixture heated at 50 °C for a further 4 h. Heating was necessary due to the lower solubility of the starting amides 20. Once again, the absolute configurations of 21 were assigned by synthesis of 21a from enantiopure (+)-(S p ) 9.
Three different procedures for the metallation of 21b were tested, including using n-BuLi, t-BuLi (both at -78 °C) and s-Bu 2 Mg.LiCl at rt, a reagent recently described by Knochel as highly effective for the metallation of aryl bromides. 39 Reaction of the organometallics, generated in these ways, with the chlorophosphine gave 70, 33 and 0% of the desired product 22b, respectively. The reaction starting with t-BuLi gave an unidentified by-product which was difficult to separate from the product and that starting with Knochel's reagent gave 29% starting material and 33% oxazolinyl [2.2] 
(-)-(S,4R P )-and (+)-(S,4S P )-4-(4-iso-Propyloxazolin-2-yl)[2.2]paracyclophane (5a and 5b)
Thionyl chloride (16.8 mL, 230. A pure sample of (-)-(S,4R P ) 5a was prepared in the same manner as that described above, but on a C NMR (100 MHz) δ 163. 4, 140.7, 139.8, 139.4, 139.2, 135.6, 134.6, 134.2, 132.8, 132.6, 132.2, 131.1, 128.4, 72.9, 69.3, 35.9, 35.3, 35.1, 34.9, 32.9, 19.2, 18 9, 140.9, 139.8, 139.3, 139.2, 135.7, 134.6, 134.1, 132.8, 132.6, 132.2, 131.2, 128.3, 73.0, 69.2, 35.8, 35.3, 34.9, 34.7, 33.4, 19.3, 18.7 
(-)-(S,4S p ,13R p )-4-Bromo-13-(4-iso-propyloxazolin-2-yl)[2.2]paracyclophane (6a)
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The diastereomeric mixture of oxazolines 5 (0.13 g, 0.40 mmol) was dissolved in dry DCM (11 mL).
Iron powder (3 mg, 0.05 mmol) was added followed by bromine (0.03 mL, 0.48 mmol) [Note: On larger scales, a solution of bromine should be added dropwise, according to the literature procedure. 24 and the mixture heated at reflux for 16 h. The reaction mixture was washed with saturated NaHCO 3 solution (2 × 10 mL) and brine (10 mL 2, 138.6, 136.6, 136.0 (C-15) , 135.9 (C-5), 134.9 (2 C, s, C-8, 16), 132.9 (C-12) = 9.8), 136.0, 135.7, 135.3, 134.7, 134.2, 133.8, 133.0, 132.83, 132.76, 130.9 The reaction mixture was allowed to warm to rt and stirred for 18 h with slow bubbling of CO 2 . The mixture was extracted twice with water (1 L, 500 mL) then aq NaOH solution (6 M, 50 mL). The combined aq layers were washed with DCM (500 mL) and Et 2 O (2 × 500 mL). The aq layer was acidified to pH 1 with aq HCl (6 M) to give a white precipitate. The mixture was then extracted with DCM (3 × 500 mL), the combined organic layers were dried over Na 2 SO 4 
(-)-(S,4S P ,5R P )-O-[4-(5-(1-hydroxymethyl-2-methyl-propylcarbamoyl)-[2.2]paracyclophanyl)]-diethylcarbamate (13a)
Thionyl chloride (2.0 mL, 27.8 mmol) was added to (±)-carboxylic acid 12 (1.81 g, 4.94 mmol) and the resulting mixture heated at 60 °C for 4 h. The excess thionyl chloride was removed by evaporation and the final traces by azeotropic distillation with toluene. The resulting crude acid chloride was dissolved in DCM (8 mL) and cooled to 0 °C. A solution of L-valinol (1.01 g, 9.78 mmol) and Et 3 N (1.37 mL, 9.78 mmol) in DCM (1 mL) was added and the reaction mixture allowed to warm to rt and stirred for 24 h.
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DCM (120 mL) was then added and the solution washed with aq NaHCO 3 solution (3.5% w/v, 2 × 120 mL) and brine (120 mL). 
(+)-(S,4R P ,5S P )-O-[4-(5-(1-hydroxymethyl-2-methyl-propylcarbamoyl)-[2.2]paracyclophanyl)]-diethylcarbamate (13b)
Further elution gave the title compound as a white solid (0.58 g, 26%); R f (DCM: EtOAc = 8:2) 6, 154.5, 146.0, 140.6, 139.6, 138.8, 136.1, 132.7, 132.5, 132.3, 132.1, 132.0, 129.3, 128.8, 63.7 (NCH) , 57.9 (CH 2 OH), 42.0 (2C, s, 2×CH 2 CH 3 ), 35.1, 34.4, 33.4, 30.3, 28.8 
(-)-(S,4S P ,5R P )-O-[2-(5-(4-hydroxy[2.2]-paracyclophanyl))-3-methylbutyl] diethylcarbamate (14a)
Carbamate 13a (0.85 g, 1.89 mmol) was dissolved in a mixture of MeOH (53 mL) and aq NaOH (6 M, 19.8 mL, 118.9 mmol 9, 159.5, 155.9, 140.1, 137.8, 137.5, 137.4, 133.0, 131.8, 131.3, 129.0, 127.7, 127.1, 117.9, 64.6 (1 H, m, H-9a), 3.48 (1 H, q, J = 7.0), 3.41 (1 H, ddd, J = 12.9, 10.2, 2.8), 3.17 (1 H, ddd, J = 12.9, 10.4, 5.2), 3.11 (1 H, m), 3.02 (1 H, ddd, J = 12.9, 10.7, 2.8) 4, 140.1, 137.9, 137.7, 137.3, 133.0, 131.8, 131.4, 129.2, 127.7, 127.1, 117.9, 63 
(+)-(S,4R P ,5S P )-O-[2-(5-(4-hydroxy[2.2]-paracyclophanyl))-3-methylbutyl] diethylcarbamate (14b)
Treatment of carbamate 13b (0.58 g, 1.29 mmol) according to the procedure for the synthesis of 14a = 13.6, 9.3, 6.7, H-9b), 2.78 (1 H, ddd, J = 12.6, 9.3, 6.7, H-10b 1, 155.4, 139.9, 137.7, 137.5, 137.2, 132.7, 131.6, 131.2, 128.9, 127.5, 126.9, 118.0 6, 159.2, 139.8, 137.9, 137.5, 137.4, 132.9, 131.6, 131.2, 129.0, 127.4, 127.2, 117.9, 63.6 (CH 2 OH), 56.7 (NCH), 36.3, 35.0, 33.8, 30.1 (C-2) 
(-)-(S,4S P ,5R P )-O-[4-(5-(4-Isopropyloxazolin-2-yl)-[2.2]paracyclophanyl)]diethylcarbamate (16a)
Carbamate 13a C NMR (100 MHz) δ 160. 4, 153.3, 148.2, 142.2, 139.4, 139.2, 136.2, 132.8, 132.5, 132.3, 131.5, 131.1, 129.3, 123.1, 73.3 (NCH) 
(-)-(S,4S P ,5R P )-Trifluoromethansulfonic acid [4-(5-(4-isopropyloxazolin-2-yl)-[2.2]paracyclophanyl)] ester (18a)
A solution of diol 15a (0.19 g, 0.53 mmol) and pyridine (0.1 mL, 1.27 mmol) in DCM (1.5 mL) was added dropwise to a solution of Tf 2 O (0.19 mL, 1.11 mmol) in DCM (0.5 mL) at 0 °C. After stirring for 1.5 h, the solution was warmed to rt and stirred for a further 2 h. Water (6 mL) was added, the aq layer separated and extracted with DCM (3 × 6 mL). The combined organic layers were dried over Na = 9.1, 7.7, CHHO), 4.18 (1 H, td, J = 9.1, 6.6, NCH), 4.10 (1 H, dd, J = 9.1, 7.7, CHHO), 3.43 (1 H, m), 3.36 (1 H, ddd, J = 13.5, 9.9, 4.1, 3.23 (1 H, ddd, J = 12.9, 9.9, 4.1), m), 2.90 (1 H, ddd, J = 13.5, 10.2, 4.1, , 2.00 (1 H, oct, J = 6.6, CH(CH 3 ) 2 ), 1.13 (3 H, d , J = 6.6, CH 3 ), 1.04 (3 H, d, J = 6.6, CH 3 );
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C NMR (100 MHz) δ 159.3 (C=N), 145.5, 143.5, 139.2, 138.9, 137.2, 134.3, 132.7, 132.4, 132.3, 131.9, 130.2, 124.1, 118.5 (q, J C-F 317.9 , CF 3 ), 73.5 (NCH), 69.6 (CH 2 O), 34.8, 34.4, 34.1, 32.6 (CH(CH 3 (2 H, s, 8), 6.58 (1 H, dd, J = 7.9, 1.7), 4.50 (1 H, dd, J = 9.9, 8.7, CHHO), 4.17 (1 H, t, J = 8.7, CHHO), 4.05 (1 H, m, NCH), 3.70 (1 H, ddd, J = 12.1, 9.6, 4.0, 3.36 (1 H, ddd, J = 13.4, 9.9, 3. 7, 143.7, 139.2, 139.1, 137.1, 134.6, 132.7, 132.5, 132.3, 130.1, 124.4, (q, J C-F 
(-)-(S,4S P ,5R P )-4-Diphenylphosphinyl-5-(4-iso-propyloxazolin-2-yl)[2.2]paracyclophane (3a)
Triflate 18a (1.05 g, 2.24 mmol) was dissolved in THF (6.5 mL) and Ph 7.56 (2 H, m), 7.34 (2 H, m), 7.15 (3 H, m), 7.10 (3 H, m), 6.87 (1 H, br.d, J = 8.0), 6.77 (1 H, br.d, J = 8.0), 6.55 (2 H, m), 6.40 (1 H, d, J = 7.8, H-7), 6.35 (1 H, dd, J = 7.8, J H-P = 3.7, H-8) = 9.5), 139.5, 138.8, 138.7, 138.3, 138.0, 135.5, 134.6, 133.3, 133.2, 133.0, 132.9, 131.7, 131.64, 131.57, 131.2, 128.5, 128.4, 128.3, 128.0 (2 C, s), 127.9, 72.7 (NCH) , 68.5 (CH 2 O), 36.4 (d, J C-P = 6.5, C-2), 34.7, 34.6, 33.5, 32.2 (CH(CH 3 9.1), 137.0, 136.8, 135.3 (2 C, s), 133.4, 133.2, 133.1, 132.9, 132.2, 132.1, 131.4, 130.9, 128.4, 128.34, 128.26, 128.2, 127.9, 127.8, 72.6 (NCH) in THF (0.5 mL) was added dropwise to give a black solution which slowly became orange. After 10 min, the cooling bath was removed and the reaction mixture stirred for a further 3 h. Ordinary 'wet' Et 3 N (0.1 mL, 0.71 mmol) was added followed by Et 2 O (3 mL) and the resulting mixture added to silica gel (1.4 g) and DCM (3 mL). The solvent was evaporated to leave the crude product mixture suspended on silica which was added to the top of a column of silica gel for flash chromatography, gradient elution = 12.9, 9.7, 6.7, H-1a) , 3.27 (1 H, br.dd, J = 13.6, 9.7, H-2a = 17.9), 140.8, 139.7, 139.5, 138.7 (d, J C-P = 10.7), 137.7, 137.3, 135.6, 134.9, 134.4, 134.3, 134.2, 134.1, 132.5, 131.6 (d, J C-P = 4.8) (1.64 g, 11.92 mmol) and Et 3 N (1.68 mL, 11.92 mmol) in DCM (6 mL) was added and the reaction mixture allowed to warm to rt and stirred for 24 h. DCM was then added (150 mL) and the solution washed with aq NaHCO 3 solution (3.5% w/v, 2 × 150 mL) and brine (150 mL). The organic phase was dried over Na 2 SO 4 , filtered and concentrated. Flash column chromatography, gradient elution (pentane:DCM:EtOAc = 5:2:3 -> 4:2:4 -> 3:2:5) was carried out and the title compound was found to crystallize in several of the fractions. This was removed by filtration. The remaining fractions consisted of mixtures of both diastereoisomers so these were evaporated and recrystallized from EtOAc and a small amount of petroleum ether. This gave more of the pure title compound. This chromatography-recrystallization procedure was repeated several times to give the title compound as a white crystalline solid (1.14 g, = 13.7, 9.6, 1.9), 3.17 (1 H, ddd, J = 12.9, 9.6, 6.9), 3.13-3.03 (3 H, m 3, 139.9, 139.5, 138.6, 138.5, 136.0, 135.4, 135.0, 134.9, 134.6, 131.5, 128.9 (2 C, s) The title compound was isolated, during the procedure described above, as a white amorphous solid = 12.4, 6.9, 4.9, 3.41 (1 H, ddd, J = 13.5, 9.6, 1.9, m, OH, 1b, 9a, 9b), m, 10b ); 13 C NMR (100 MHz) δ 168.9 (C=O), 142.0, 139.7, 139.4, 139.0, 138.4, 135.7, 135.4, 135.0, 134.6, 134.0, 131.2, 128.7 (2 C, s), 127.6, 126.9, 126 8, 142.1, 140.8, 139.3, 138.8, 135.8, 135.4, 135.1, 135.0, 131.2, 130.6 (C-13), 128.7 (2 C, s), 127.7, 127.4, 126.7 (2 C, s) 7, 141.2, 139.8, 139.5, 139.3, 135.9, 135.1, 134.4, 132.9, 132.7, 132.3, 131.3, 128.7 (2 C, s), 127.9, 127.5, 126.7 (2 C, s) 
